Australia, Jan. 28 -- RayzeBio Inc., owns the trademark (2603566) for 'RAYZACT' till Nov. 13, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations.] and 5 [All items in this class are claimed in the convention application.]
Type of Mark: Word
Date of Acceptance: Nov. 19, 2025
Registration Advertised: Jan. 27
For further details contact Spruson & Ferguson.
The original docu...